サマリー

欧州の検査キット市場 2023-2027
欧州の検査キット市場は、2022-2027年に-172.9億米ドルの成長が予測され、予測期間中のCAGRは-23.8%で減速すると予測されています。当レポートでは、欧州の検査キット市場について、市場規模や予測、動向、成長促進要因、課題などの全体的な分析に加え、約25のベンダーを網羅したベンダー分析も掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場を牽引しているのは、政府からの資金提供の増加、COVID-19パンデミックの拡大防止への関心の高まり、戦略的提携の増加などです。
Technavioの欧州の検査キット市場は以下のように区分されます：
エンドユーザー別
- 政府機関
- 非政府
タイプ別
- 迅速検査キット
- RT-PCR法
- その他
本調査では、SARS-CoV-2変異の出現が、今後数年間における欧州の検査キット市場の成長を牽引する主要因の1つであるとしている。また、ポイントオブケア診断の需要増加や迅速診断製品の採用増加も市場の大きな需要につながる。
この調査レポートは欧州の検査キット市場を分析・予測し、以下のてこ入れを行います：
- 欧州の検査キット市場規模
- 欧州の検査キット市場予測
- 欧州の検査キット市場産業分析
本レポートでは、欧州の検査キット市場をリードするベンダー（3D Biomedicine Science and Technology Co.Ltd.、Abbott Laboratories、altona Diagnostics GmbH、BGI Genomics Co.Ltd.、Bio Rad Laboratories Inc.、bioMerieux SA、BIOSYNEX SA、Bruker Corp.、Co Diagnostics Inc.、Danaher Corp.、Edinburgh Genetics Ltd.、F. Hoffmann La Roche Ltd.、MultiplexDX、PerkinElmer Inc.、QIAGEN NV、Robert Bosch GmbH、Sd Biosensor Inc.、Seegene Inc.、Thermo Fisher Scientific Inc.、ZEKMEDを含む。また、欧州の検査キット市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/corona-virus-test-kits-market-in-europe-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary €“ Chart on Market Overview
o Exhibit 02: Executive Summary €“ Data Table on Market Overview
o Exhibit 03: Executive Summary €“ Chart on Country Market Characteristics
o Exhibit 04: Executive Summary €“ Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary €“ Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary €“ Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary €“ Chart on Incremental Growth
o Exhibit 08: Executive Summary €“ Data Table on Incremental Growth
o Exhibit 09: Executive Summary €“ Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Regional - Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Europe: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Regional - Market size and forecast 2022-2027 ($ billion)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 18: Five forces analysis - Comparison between 2022 and 2027
o 4.2 Bargaining power of buyers
o Exhibit 19: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027
o 4.3 Bargaining power of suppliers
o Exhibit 20: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027
o 4.4 Threat of new entrants
o Exhibit 21: Threat of new entrants €“ Impact of key factors in 2022 and 2027
o 4.5 Threat of substitutes
o Exhibit 22: Threat of substitutes €“ Impact of key factors in 2022 and 2027
o 4.6 Threat of rivalry
o Exhibit 23: Threat of rivalry €“ Impact of key factors in 2022 and 2027
o 4.7 Market condition
o Exhibit 24: Chart on Market condition - Five forces 2022 and 2027
• 5 Market Segmentation by End-user
o 5.1 Market segments
o Exhibit 25: Chart on End-user - Market share 2022-2027 (%)
o Exhibit 26: Data Table on End-user - Market share 2022-2027 (%)
o 5.2 Comparison by End-user
o Exhibit 27: Chart on Comparison by End-user
o Exhibit 28: Data Table on Comparison by End-user
o 5.3 Government - Market size and forecast 2022-2027
o Exhibit 29: Chart on Government - Market size and forecast 2022-2027 ($ billion)
o Exhibit 30: Data Table on Government - Market size and forecast 2022-2027 ($ billion)
o Exhibit 31: Chart on Government - Year-over-year growth 2022-2027 (%)
o Exhibit 32: Data Table on Government - Year-over-year growth 2022-2027 (%)
o 5.4 Non-government - Market size and forecast 2022-2027
o Exhibit 33: Chart on Non-government - Market size and forecast 2022-2027 ($ billion)
o Exhibit 34: Data Table on Non-government - Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Chart on Non-government - Year-over-year growth 2022-2027 (%)
o Exhibit 36: Data Table on Non-government - Year-over-year growth 2022-2027 (%)
o 5.5 Market opportunity by End-user
o Exhibit 37: Market opportunity by End-user ($ billion)
o Exhibit 38: Data Table on Market opportunity by End-user ($ billion)
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 39: Chart on Type - Market share 2022-2027 (%)
o Exhibit 40: Data Table on Type - Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 41: Chart on Comparison by Type
o Exhibit 42: Data Table on Comparison by Type
o 6.3 Rapid test kit - Market size and forecast 2022-2027
o Exhibit 43: Chart on Rapid test kit - Market size and forecast 2022-2027 ($ billion)
o Exhibit 44: Data Table on Rapid test kit - Market size and forecast 2022-2027 ($ billion)
o Exhibit 45: Chart on Rapid test kit - Year-over-year growth 2022-2027 (%)
o Exhibit 46: Data Table on Rapid test kit - Year-over-year growth 2022-2027 (%)
o 6.4 RT-PCR - Market size and forecast 2022-2027
o Exhibit 47: Chart on RT-PCR - Market size and forecast 2022-2027 ($ billion)
o Exhibit 48: Data Table on RT-PCR - Market size and forecast 2022-2027 ($ billion)
o Exhibit 49: Chart on RT-PCR - Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on RT-PCR - Year-over-year growth 2022-2027 (%)
o 6.5 Others - Market size and forecast 2022-2027
o Exhibit 51: Chart on Others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 52: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 53: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Type
o Exhibit 55: Market opportunity by Type ($ billion)
o Exhibit 56: Data Table on Market opportunity by Type ($ billion)
• 7 Customer Landscape
o 7.1 Customer landscape overview
o Exhibit 57: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 8 Geographic Landscape
o 8.1 Geographic segmentation
o Exhibit 58: Chart on Market share By Geographical Landscape - 2022-2027 (%)
o Exhibit 59: Data Table on Market share By Geographical Landscape - 2022-2027 (%)
o 8.2 Geographic comparison
o Exhibit 60: Chart on Geographic comparison
o Exhibit 61: Data Table on Geographic comparison
o 8.3 UK - Market size and forecast 2022-2027
o Exhibit 62: Chart on UK - Market size and forecast 2022-2027 ($ billion)
o Exhibit 63: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
o Exhibit 64: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 65: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 8.4 Spain - Market size and forecast 2022-2027
o Exhibit 66: Chart on Spain - Market size and forecast 2022-2027 ($ billion)
o Exhibit 67: Data Table on Spain - Market size and forecast 2022-2027 ($ billion)
o Exhibit 68: Chart on Spain - Year-over-year growth 2022-2027 (%)
o Exhibit 69: Data Table on Spain - Year-over-year growth 2022-2027 (%)
o 8.5 Russia - Market size and forecast 2022-2027
o Exhibit 70: Chart on Russia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 71: Data Table on Russia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 72: Chart on Russia - Year-over-year growth 2022-2027 (%)
o Exhibit 73: Data Table on Russia - Year-over-year growth 2022-2027 (%)
o 8.6 France - Market size and forecast 2022-2027
o Exhibit 74: Chart on France - Market size and forecast 2022-2027 ($ billion)
o Exhibit 75: Data Table on France - Market size and forecast 2022-2027 ($ billion)
o Exhibit 76: Chart on France - Year-over-year growth 2022-2027 (%)
o Exhibit 77: Data Table on France - Year-over-year growth 2022-2027 (%)
o 8.7 Rest of Europe - Market size and forecast 2022-2027
o Exhibit 78: Chart on Rest of Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 79: Data Table on Rest of Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 80: Chart on Rest of Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 81: Data Table on Rest of Europe - Year-over-year growth 2022-2027 (%)
o 8.8 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 83: Data Table on Market opportunity By Geographical Landscape ($ billion)
• 9 Drivers, Challenges, and Trends
o 9.1 Market drivers
o 9.2 Market challenges
o 9.3 Impact of drivers and challenges
o Exhibit 84: Impact of drivers and challenges in 2022 and 2027
o 9.4 Market trends
• 10 Vendor Landscape
o 10.1 Overview
o 10.2 Vendor landscape
o Exhibit 85: Overview on Criticality of inputs and Factors of differentiation
o 10.3 Landscape disruption
o Exhibit 86: Overview on factors of disruption
o 10.4 Industry risks
o Exhibit 87: Impact of key risks on business
• 11 Vendor Analysis
o 11.1 Vendors covered
o Exhibit 88: Vendors covered
o 11.2 Market positioning of vendors
o Exhibit 89: Matrix on vendor position and classification
o 11.3 3D Biomedicine Science and Technology Co. Ltd.
o Exhibit 90: 3D Biomedicine Science and Technology Co. Ltd. - Overview
o Exhibit 91: 3D Biomedicine Science and Technology Co. Ltd. - Product / Service
o Exhibit 92: 3D Biomedicine Science and Technology Co. Ltd. - Key offerings
o 11.4 Abbott Laboratories
o Exhibit 93: Abbott Laboratories - Overview
o Exhibit 94: Abbott Laboratories - Business segments
o Exhibit 95: Abbott Laboratories - Key news
o Exhibit 96: Abbott Laboratories - Key offerings
o Exhibit 97: Abbott Laboratories - Segment focus
o 11.5 altona Diagnostics GmbH
o Exhibit 98: altona Diagnostics GmbH - Overview
o Exhibit 99: altona Diagnostics GmbH - Product / Service
o Exhibit 100: altona Diagnostics GmbH - Key offerings
o 11.6 BGI Genomics Co. Ltd.
o Exhibit 101: BGI Genomics Co. Ltd. - Overview
o Exhibit 102: BGI Genomics Co. Ltd. - Product / Service
o Exhibit 103: BGI Genomics Co. Ltd. - Key offerings
o 11.7 Bio Rad Laboratories Inc.
o Exhibit 104: Bio Rad Laboratories Inc. - Overview
o Exhibit 105: Bio Rad Laboratories Inc. - Business segments
o Exhibit 106: Bio Rad Laboratories Inc. - Key news
o Exhibit 107: Bio Rad Laboratories Inc. - Key offerings
o Exhibit 108: Bio Rad Laboratories Inc. - Segment focus
o 11.8 bioMerieux SA
o Exhibit 109: bioMerieux SA - Overview
o Exhibit 110: bioMerieux SA - Product / Service
o Exhibit 111: bioMerieux SA - Key offerings
o 11.9 BIOSYNEX SA
o Exhibit 112: BIOSYNEX SA - Overview
o Exhibit 113: BIOSYNEX SA - Product / Service
o Exhibit 114: BIOSYNEX SA - Key offerings
o 11.10 Bruker Corp.
o Exhibit 115: Bruker Corp. - Overview
o Exhibit 116: Bruker Corp. - Business segments
o Exhibit 117: Bruker Corp. - Key news
o Exhibit 118: Bruker Corp. - Key offerings
o Exhibit 119: Bruker Corp. - Segment focus
o 11.11 Co Diagnostics Inc.
o Exhibit 120: Co Diagnostics Inc. - Overview
o Exhibit 121: Co Diagnostics Inc. - Product / Service
o Exhibit 122: Co Diagnostics Inc. - Key news
o Exhibit 123: Co Diagnostics Inc. - Key offerings
o 11.12 Danaher Corp.
o Exhibit 124: Danaher Corp. - Overview
o Exhibit 125: Danaher Corp. - Business segments
o Exhibit 126: Danaher Corp. - Key news
o Exhibit 127: Danaher Corp. - Key offerings
o Exhibit 128: Danaher Corp. - Segment focus
o 11.13 Edinburgh Genetics Ltd.
o Exhibit 129: Edinburgh Genetics Ltd. - Overview
o Exhibit 130: Edinburgh Genetics Ltd. - Product / Service
o Exhibit 131: Edinburgh Genetics Ltd. - Key offerings
o 11.14 F. Hoffmann La Roche Ltd.
o Exhibit 132: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 133: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 134: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 135: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 136: F. Hoffmann La Roche Ltd. - Segment focus
o 11.15 QIAGEN NV
o Exhibit 137: QIAGEN NV - Overview
o Exhibit 138: QIAGEN NV - Product / Service
o Exhibit 139: QIAGEN NV - Key news
o Exhibit 140: QIAGEN NV - Key offerings
o 11.16 Thermo Fisher Scientific Inc.
o Exhibit 141: Thermo Fisher Scientific Inc. - Overview
o Exhibit 142: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 143: Thermo Fisher Scientific Inc. - Key news
o Exhibit 144: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 145: Thermo Fisher Scientific Inc. - Segment focus
o 11.17 ZEKMED
o Exhibit 146: ZEKMED - Overview
o Exhibit 147: ZEKMED - Product / Service
o Exhibit 148: ZEKMED - Key offerings
• 12 Appendix
o 12.1 Scope of the report
o 12.2 Inclusions and exclusions checklist
o Exhibit 149: Inclusions checklist
o Exhibit 150: Exclusions checklist
o 12.3 Currency conversion rates for US$
o Exhibit 151: Currency conversion rates for US$
o 12.4 Research methodology
o Exhibit 152: Research methodology
o Exhibit 153: Validation techniques employed for market sizing
o Exhibit 154: Information sources
o 12.5 List of abbreviations
o Exhibit 155: List of abbreviations
o generated by emerging segments in healthcare: Growing adoption of healthcare supplies for home-based healthcare, home medical devices, and other advanced application areas such as robotic surgery will aid in the growth of this market.


Exhibits:
Exhibits1: Executive Summary €“ Chart on Market Overview
Exhibits2: Executive Summary €“ Data Table on Market Overview
Exhibits3: Executive Summary €“ Chart on Country Market Characteristics
Exhibits4: Executive Summary €“ Chart on Market By Geographical Landscape
Exhibits5: Executive Summary €“ Chart on Market Segmentation by End-user
Exhibits6: Executive Summary €“ Chart on Market Segmentation by Type
Exhibits7: Executive Summary €“ Chart on Incremental Growth
Exhibits8: Executive Summary €“ Data Table on Incremental Growth
Exhibits9: Executive Summary €“ Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Regional - Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Europe: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Regional - Market size and forecast 2022-2027 ($ billion)
Exhibits18: Five forces analysis - Comparison between 2022 and 2027
Exhibits19: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027
Exhibits20: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027
Exhibits21: Threat of new entrants €“ Impact of key factors in 2022 and 2027
Exhibits22: Threat of substitutes €“ Impact of key factors in 2022 and 2027
Exhibits23: Threat of rivalry €“ Impact of key factors in 2022 and 2027
Exhibits24: Chart on Market condition - Five forces 2022 and 2027
Exhibits25: Chart on End-user - Market share 2022-2027 (%)
Exhibits26: Data Table on End-user - Market share 2022-2027 (%)
Exhibits27: Chart on Comparison by End-user
Exhibits28: Data Table on Comparison by End-user
Exhibits29: Chart on Government - Market size and forecast 2022-2027 ($ billion)
Exhibits30: Data Table on Government - Market size and forecast 2022-2027 ($ billion)
Exhibits31: Chart on Government - Year-over-year growth 2022-2027 (%)
Exhibits32: Data Table on Government - Year-over-year growth 2022-2027 (%)
Exhibits33: Chart on Non-government - Market size and forecast 2022-2027 ($ billion)
Exhibits34: Data Table on Non-government - Market size and forecast 2022-2027 ($ billion)
Exhibits35: Chart on Non-government - Year-over-year growth 2022-2027 (%)
Exhibits36: Data Table on Non-government - Year-over-year growth 2022-2027 (%)
Exhibits37: Market opportunity by End-user ($ billion)
Exhibits38: Data Table on Market opportunity by End-user ($ billion)
Exhibits39: Chart on Type - Market share 2022-2027 (%)
Exhibits40: Data Table on Type - Market share 2022-2027 (%)
Exhibits41: Chart on Comparison by Type
Exhibits42: Data Table on Comparison by Type
Exhibits43: Chart on Rapid test kit - Market size and forecast 2022-2027 ($ billion)
Exhibits44: Data Table on Rapid test kit - Market size and forecast 2022-2027 ($ billion)
Exhibits45: Chart on Rapid test kit - Year-over-year growth 2022-2027 (%)
Exhibits46: Data Table on Rapid test kit - Year-over-year growth 2022-2027 (%)
Exhibits47: Chart on RT-PCR - Market size and forecast 2022-2027 ($ billion)
Exhibits48: Data Table on RT-PCR - Market size and forecast 2022-2027 ($ billion)
Exhibits49: Chart on RT-PCR - Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on RT-PCR - Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits52: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits53: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits55: Market opportunity by Type ($ billion)
Exhibits56: Data Table on Market opportunity by Type ($ billion)
Exhibits57: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits58: Chart on Market share By Geographical Landscape - 2022-2027 (%)
Exhibits59: Data Table on Market share By Geographical Landscape - 2022-2027 (%)
Exhibits60: Chart on Geographic comparison
Exhibits61: Data Table on Geographic comparison
Exhibits62: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits63: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits64: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits65: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits66: Chart on Spain - Market size and forecast 2022-2027 ($ billion)
Exhibits67: Data Table on Spain - Market size and forecast 2022-2027 ($ billion)
Exhibits68: Chart on Spain - Year-over-year growth 2022-2027 (%)
Exhibits69: Data Table on Spain - Year-over-year growth 2022-2027 (%)
Exhibits70: Chart on Russia - Market size and forecast 2022-2027 ($ billion)
Exhibits71: Data Table on Russia - Market size and forecast 2022-2027 ($ billion)
Exhibits72: Chart on Russia - Year-over-year growth 2022-2027 (%)
Exhibits73: Data Table on Russia - Year-over-year growth 2022-2027 (%)
Exhibits74: Chart on France - Market size and forecast 2022-2027 ($ billion)
Exhibits75: Data Table on France - Market size and forecast 2022-2027 ($ billion)
Exhibits76: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits77: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits78: Chart on Rest of Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits79: Data Table on Rest of Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits80: Chart on Rest of Europe - Year-over-year growth 2022-2027 (%)
Exhibits81: Data Table on Rest of Europe - Year-over-year growth 2022-2027 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ billion)
Exhibits83: Data Table on Market opportunity By Geographical Landscape ($ billion)
Exhibits84: Impact of drivers and challenges in 2022 and 2027
Exhibits85: Overview on Criticality of inputs and Factors of differentiation
Exhibits86: Overview on factors of disruption
Exhibits87: Impact of key risks on business
Exhibits88: Vendors covered
Exhibits89: Matrix on vendor position and classification
Exhibits90: 3D Biomedicine Science and Technology Co. Ltd. - Overview
Exhibits91: 3D Biomedicine Science and Technology Co. Ltd. - Product / Service
Exhibits92: 3D Biomedicine Science and Technology Co. Ltd. - Key offerings
Exhibits93: Abbott Laboratories - Overview
Exhibits94: Abbott Laboratories - Business segments
Exhibits95: Abbott Laboratories - Key news
Exhibits96: Abbott Laboratories - Key offerings
Exhibits97: Abbott Laboratories - Segment focus
Exhibits98: altona Diagnostics GmbH - Overview
Exhibits99: altona Diagnostics GmbH - Product / Service
Exhibits100: altona Diagnostics GmbH - Key offerings
Exhibits101: BGI Genomics Co. Ltd. - Overview
Exhibits102: BGI Genomics Co. Ltd. - Product / Service
Exhibits103: BGI Genomics Co. Ltd. - Key offerings
Exhibits104: Bio Rad Laboratories Inc. - Overview
Exhibits105: Bio Rad Laboratories Inc. - Business segments
Exhibits106: Bio Rad Laboratories Inc. - Key news
Exhibits107: Bio Rad Laboratories Inc. - Key offerings
Exhibits108: Bio Rad Laboratories Inc. - Segment focus
Exhibits109: bioMerieux SA - Overview
Exhibits110: bioMerieux SA - Product / Service
Exhibits111: bioMerieux SA - Key offerings
Exhibits112: BIOSYNEX SA - Overview
Exhibits113: BIOSYNEX SA - Product / Service
Exhibits114: BIOSYNEX SA - Key offerings
Exhibits115: Bruker Corp. - Overview
Exhibits116: Bruker Corp. - Business segments
Exhibits117: Bruker Corp. - Key news
Exhibits118: Bruker Corp. - Key offerings
Exhibits119: Bruker Corp. - Segment focus
Exhibits120: Co Diagnostics Inc. - Overview
Exhibits121: Co Diagnostics Inc. - Product / Service
Exhibits122: Co Diagnostics Inc. - Key news
Exhibits123: Co Diagnostics Inc. - Key offerings
Exhibits124: Danaher Corp. - Overview
Exhibits125: Danaher Corp. - Business segments
Exhibits126: Danaher Corp. - Key news
Exhibits127: Danaher Corp. - Key offerings
Exhibits128: Danaher Corp. - Segment focus
Exhibits129: Edinburgh Genetics Ltd. - Overview
Exhibits130: Edinburgh Genetics Ltd. - Product / Service
Exhibits131: Edinburgh Genetics Ltd. - Key offerings
Exhibits132: F. Hoffmann La Roche Ltd. - Overview
Exhibits133: F. Hoffmann La Roche Ltd. - Business segments
Exhibits134: F. Hoffmann La Roche Ltd. - Key news
Exhibits135: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits136: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits137: QIAGEN NV - Overview
Exhibits138: QIAGEN NV - Product / Service
Exhibits139: QIAGEN NV - Key news
Exhibits140: QIAGEN NV - Key offerings
Exhibits141: Thermo Fisher Scientific Inc. - Overview
Exhibits142: Thermo Fisher Scientific Inc. - Business segments
Exhibits143: Thermo Fisher Scientific Inc. - Key news
Exhibits144: Thermo Fisher Scientific Inc. - Key offerings
Exhibits145: Thermo Fisher Scientific Inc. - Segment focus
Exhibits146: ZEKMED - Overview
Exhibits147: ZEKMED - Product / Service
Exhibits148: ZEKMED - Key offerings
Exhibits149: Inclusions checklist
Exhibits150: Exclusions checklist
Exhibits151: Currency conversion rates for US$
Exhibits152: Research methodology
Exhibits153: Validation techniques employed for market sizing
Exhibits154: Information sources
Exhibits155: List of abbreviations